Current perspectives on the gleason grading of prostate cancer

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 11, 2009, Pages 1810-1816

  Shah, Rajal B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CONFERENCE PAPER; GLEASON SCORE; HUMAN; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

ADENOCARCINOMA; BIOPSY, NEEDLE; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 70449346550     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Bailar JC III, Mellinger GT, Gleason DF. Survival rates of patients with prostatic cancer, tumor stage, and differentiation - preliminary report. Cancer Chemother Rep. 1966;50(3):129-136.
2. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50(3):125-128.
3. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol. 1974;111(1):58-64.
4. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumors; vol 7.
5. Ennis RD, Malyszko BK, Rescigno J, et al. Biologic classification as an alternative to anatomic staging for clinically localized prostate cancer: a proposal based on patients treated with external beam radiotherapy. Urology. 1998;51(2):265-270. (Pubitemid 28093179)
6. Roehl KA, Han M, Ramos CG, et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol. 2004;172(3):910-914. (Pubitemid 39096421)
7. Schwartz E, Albertsen P. Nomograms for clinically localized disease - part III: watchful waiting. Semin Urol Oncol. 2002;20(2):140-145. (Pubitemid 34522552)
8. Zagars GK, Pollack A, von Eschenbach AC. Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era. Cancer. 1997;79(7):1370-1380. (Pubitemid 27143245)
9. Bentley G, Dey J, Sakr WA, et al. Significance of the Gleason scoring system after neoadjuvant hormonal therapy [discussion in Mol Urol. 2000;4(3):131]. Mol Urol. 2000;4(3):125. (Pubitemid 30808864)
10. Kattan MW, Eastham J. Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer. Clin Prostate Cancer. 2003;1(4):221-226. (Pubitemid 37021458)
11. Kattan MW, Scardino PT. Prediction of progression: nomograms of clinical utility. Clin Prostate Cancer. 2002;1(2):90-96.
12. Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001;58(6):843-848.
13. Pisansky TM, Kahn MJ, Rasp GM, et al. A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma. Cancer. 1997;79(2):337-344.
14. Siu W, Dunn RL, Shah RB, et al. Use of extended pattern technique for initial prostate biopsy. J Urol. 2005;174(2):505-509. (Pubitemid 40981585)
15. Amin MB, Schultz DS, Zarbo RJ. Analysis of cribriform morphology in prostatic neoplasia using antibody to high-molecular-weight cytokeratins. Arch Pathol Lab Med. 1994;118(3):260-264.
16. Epstein JI, Allsbrook WC Jr, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29(9):1228-1242.
17. Epstein JI. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. Am J Surg Pathol. 2000;24(4):477-478.
18. Latour M, Amin MB, Billis A, et al. Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am J Surg Pathol. 2008;32(10):1532-1539.
19. Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol. 1999;23(12):1471-1479.
20. Wu AJ, Daignault S, Wasco MJ, et al. Correlation of biopsy and radical prostatectomy Gleason score in contemporary extended >=12 core biopsy practice: improved correlation with biopsy worst Gleason score. Mod Pathol. 2008;21(suppl 1):190A.
21. Kunz GM Jr, Epstein JI. Should each core with prostate cancer be assigned a separate gleason score? Hum Pathol. 2003;34(9):911-914.
22. Rubin MA, Bismar TA, Curtis S, et al. Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients? Am J Surg Pathol. 2004;28(7):946-952.
23. Kunju LP, Daignault S, Wei JT, et al. Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score? Hum Pathol. 2009;40(4):558-564.
24. Mosse CA, Magi-Galluzzi C, Tsuzuki T, et al. The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens. Am J Surg Pathol. 2004;28(3):394-398. (Pubitemid 38269575)
25. Pan CC, Potter SR, Partin AW, et al. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol. 2000;24(4):563-569.
26. Trpkov K, Zhang J, Chan M, et al. Prostate cancer with tertiary Gleason pattern 5 in prostate needle biopsy: clinicopathologic findings and disease progression. Am J Surg Pathol. 2009;33(2):233-240.
27. Shah R, Daignault S, Kunju LP, et al. Significance of tertiary pattern 5 in prostate needle biopsies with Gleason score of 3+4 or 4+3 prostate cancer: pathologic correlation following radical prostatectomy. Mod Pathol. 2009;22(suppl 1):193A.
28. McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini: morphologic and clinical correlations. Am J Surg Pathol. 1996;20(7):802-814.
29. Cohen RJ, Wheeler TM, Bonkhoff H, et al. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma. Arch Pathol Lab Med. 2007;131(7):1103-1109. (Pubitemid 47057901)
30. Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol. 2006;19(12):1528-1535. (Pubitemid 44789920)
31. Tran TT, Sengupta E, Yang XJ. Prostatic foamy gland carcinoma with aggressive behavior: clinicopathologic, immunohistochemical, and ultrastructural analysis. Am J Surg Pathol. 2001;25(5):618-623. (Pubitemid 32423359)
32. Lane BR, Magi-Galluzzi C, Reuther AM, et al. Mucinous adenocarcinoma of the prostate does not confer poor prognosis. Urology. 2006;68(4):825-830. (Pubitemid 44633368)
33. Rubin MA, Mucci NR, Manley S, et al. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively? J Urol. 2001;165(1):114-118.
34. Stamey TA, McNeal JE, Yemoto CM, et al. Biological determinants of cancer progression in men with prostate cancer. JAMA. 1999;281(15):1395-1400. (Pubitemid 29190217)
35. Mehra R, Han B, Tomlins SA, et al. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res. 2007;67(17):7991-7995. (Pubitemid 47395131)
36. Billis A, Guimaraes MS, Freitas LL, et al. The impact of the 2005 International Society of Urological Pathology Consensus Conference on Standard Gleason Grading of Prostatic Carcinoma in Needle Biopsies [discussion in J Urol. 2008;180(2):52-53.]. J Urol. 2008;180(2):548-552.
37. Bostwick DG. Gleason grading of prostatic needle biopsies: correlation with grade in 316 matched prostatectomies. Am J Surg Pathol. 1994;18(8):796-803.
38. Cookson MS, Fleshner NE, Soloway SM, et al. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol. 1997;157(2):559-562. (Pubitemid 27026838)
39. Steinberg DM, Sauvageot J, Piantadosi S, et al. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol. 1997;21(5):566-576. (Pubitemid 27213072)
40. Emiliozzi P, Maymone S, Paterno A, et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. J Urol. 2004;172(6, pt 1):2224-2226. (Pubitemid 39507496)
41. King CR, McNeal JE, Gill H, et al. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys. 2004;59(2):386-391. (Pubitemid 38622590)